EODData

MEMBERSHIP REGISTER LOG IN

FRA, PBDA: PROTALIX BIOTHERAP.DL-01

19 May 2026
LAST:

1.644

CHANGE:
 0.02		OPEN:
1.606		HIGH:
1.686		ASK:
0.000		VOLUME:
0
CHG(%):
0.98		PREV:
1.628		LOW:
1.606		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
19 May 261.6061.6861.6061.6440
18 May 261.6581.7241.6281.6280
15 May 261.6801.7081.6801.7020
14 May 261.6201.7361.6201.7360
13 May 261.5961.7581.5961.6280
12 May 261.6161.6481.6001.6240
11 May 261.6141.6441.6141.6280
08 May 261.6561.6561.6281.6280
06 May 261.6421.7001.6421.7000
05 May 261.7901.8001.6561.6560

PROFILE

Name:PROTALIX BIOTHERAP.DL-01
About:Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. It operates in the United States, Australia, Canada, Israel, Brazil, Russia, and Turkey. The company is headquartered in Hackensack. New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:2 University Plaza, Hackensack, NJ, United States, 07601
Website:https://www.protalix.com
ISIN:US74365A3095
LEI:549300SDVB3GP4XDFM60

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:21.14 
Forward P/E:37.00 
PEG Ratio:-0.85 
Price to Sales:1.92 
Price to Book:2.65 
Profit Margin:0.09 
Operating Margin:0.12 
Return on Assets:0.06 
Return on Equity:0.13 
Revenue:52.53M 
EBITDA:5.54M 
Shares:79.73M 
Market Cap:131.08M 

TECHNICAL INDICATORS

MA5:1.671.4%
MA10:1.660.8%
MA20:1.756.3%
MA50:1.9116.4%
MA100:1.9317.6%
MA200:1.777.8%
STO9:14.93 
STO14:10.10 
RSI14:33.57 
WPR14:-89.80 
MTM14:-0.16
ROC14:-0.09 
ATR:0.07 
Week High:1.766.9%
Week Low:1.603.0%
Month High:1.9720.0%
Month Low:1.607.8%
Year High:2.6661.8%
Year Low:1.1444.2%

RECENT SPLITS

Date Ratio
20 Dec 20191-10